Evidence-Based Medicine Guidelines
Dabigatran versus vitamin K antagonists in non-valvular atrial fibrillation
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Dabigatran Versus Vitamin K Antagonists in Non-valvular Atrial Fibrillation." Evidence-Based Medicine Guidelines, John Wiley & Sons, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/458232/all/Dabigatran_versus_vitamin_K_antagonists_in_non_valvular_atrial_fibrillation.
Dabigatran versus vitamin K antagonists in non-valvular atrial fibrillation. Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. https://evidence.unboundmedicine.com/evidence/view/EBMG/458232/all/Dabigatran_versus_vitamin_K_antagonists_in_non_valvular_atrial_fibrillation. Accessed May 13, 2025.
Dabigatran versus vitamin K antagonists in non-valvular atrial fibrillation. (2025). In Evidence-Based Medicine Guidelines. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/EBMG/458232/all/Dabigatran_versus_vitamin_K_antagonists_in_non_valvular_atrial_fibrillation
Dabigatran Versus Vitamin K Antagonists in Non-valvular Atrial Fibrillation [Internet]. In: Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. [cited 2025 May 13]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/458232/all/Dabigatran_versus_vitamin_K_antagonists_in_non_valvular_atrial_fibrillation.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Dabigatran versus vitamin K antagonists in non-valvular atrial fibrillation
ID - 458232
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/458232/all/Dabigatran_versus_vitamin_K_antagonists_in_non_valvular_atrial_fibrillation
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
